Cardiovascular Systems (CSII) guides its FQ1 lower, now seeing revenue at $18.7M. The company says a shift in peripheral arterial disease procedures to physician-based labs caused hospital-based procedures and related purchases to decrease. Shares -7.9% AH.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs